Skip to content

The clinical prognosis study of the inflammatory demyelinating diseases in central nervous system (CNS)

The characteristics of the capital--The clinical prognosis study of the inflammatory demyelinating diseases in central nervous system (CNS)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-POC-15006265
Enrollment
Unknown
Registered
2015-04-17
Start date
2015-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the inflammatory demyelinating diseases in central nervous system (CNS)

Interventions

Sponsors

The Chinese people's Liberation Army Navy General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. acute or subacute demyelinating for onset of CNS, the pathological changes of spinal cord, brain stem, cerebellum or optic nerve, etc., can also be used for the hemisphere; 2. the duration of symptoms for 24 hours, or course of general < 3 months; 3. the progress of the disease of time evolution and space cannot meet the diagnostic criteria for MS; 4. head and spinal cord MRI performance conforms to the characteristics of demyelinating; 5. each patients are detailed answer neural system disease history and physical examination, and the examination of the eye; 6. except other CNS demyelinating cases, such as accompanied by fever and clear the infection.

Exclusion criteria

Exclusion criteria: Other CNS diseases patients; Patients with severe internal system disease; Psychiatric patients; Not signed informed consent to patients.

Design outcomes

Primary

MeasureTime frame
symptom;The nervous system of physical;neuroimaging;nerve electrophysiology;humoral factors;EDSS;

Countries

China

Contacts

Public ContactHairong Qian
bjqhr@hotmail.com+86 18600311067

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026